NASDAQ:CYTK

Cytokinetics, Incorporated Earning Date

USA |NASDAQ |USD

CYTK Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 2, 2021 Sep 2021 $-0.76 $-0.86 $-0.05
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 2, 2021 Sep 2021 $6.66M $2.84M $41.69M

Cytokinetics, Incorporated's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 2021.

CYTK Earnings Date & History Chart

CYTK Earnings & Revenue Forecast

CYTK Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-0.86 $-1.35 $-0.61
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-3.13 $-3.88 $-2.85
Dec 2022 9 $-3.24 $-3.87 $-2.18

CYTK Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.88 $-0.70 $-0.70
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-3.19 $-2.62 $-2.62
Dec 2022 1 / 0 $-3.35 $-3.06 $-3.09

CYTK Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $7.24M $6.04M $9.61M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $23.43M $15.00M $27.50M
Dec 2022 9 $28.27M $0.00 $81.54M

CYTK Earnings Date & Revenue History

CYTK Earnings History

|
Show More
Show More

CYTK Revenue History

|
Show More
Show More

Cytokinetics, Incorporated Next Earnings Date & Report

CYTK Next Earnings Date & Report Preview: Sep 2021 (FQ)

CYTK's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 8 analysts, the average EPS estimation for Cytokinetics, Incorporated's next quarterly earnings is $-0.76, with a low EPS estimation of $-0.93, and a high estimation of $-0.67.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.78, the last 2 month trend is $-0.62, and the 3 month trend is $-0.62.

Based on 6 analysts, the average revenue estimation is $6.66M, with a low revenue estimation of $6.00M, and a high estimation of $8.00M.

Cytokinetics, Incorporated Previous Earnings Dates & Reports

CYTK Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cytokinetics, Incorporated's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

CYTK's earnings per share (EPS) was $-0.86, missing the consensus analysts forecast of $-0.66 by -29.65%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 30.30%, and lower than the same period a year before (Jun 2020) by 26.47%.

Revenues were $2.84M, better than the forecast of $2.84M by 0.00%, down by -56.58% from the previous quarter , and down by -20.87% from the same period last year.

The company reported a net income of $-61.55M.

Free cash flow for the quarter was $-38.29M , compared to $-36.15M last quarter and $-28.30M a year before.

CYTK ended the quarter with $250.70M in total debt, an increase of 9.80% compared to the previous quarter, and a decrease of -11.82% compared to the same quarter a year before.

CYTK Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cytokinetics, Incorporated's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

CYTK's earnings per share (EPS) was $-2.01, missing the consensus analysts forecast of $-1.57 by 28.03% , and higher than the previous year's EPS (Dec 2019) by -5.19%.

Revenues were $55.83M, worse than the forecast of $79.04M by -29.37%, and up by 107.79% from previous year's revenue.

The company reported a net income of $-127.29M.

Cytokinetics, Incorporated reported a free cash flow of $-2.11M for its fiscal year, compared to $-93.53M a year ago.

The company ended the fiscal year with $138.50M in total debt, an increase of 3.45% compared to the previous year.